16 February 2021 After those most at risk of dying or becoming seriously ill from Covid-19 have been vaccinated, there are differing views on which groups should be prioritised next, say Dr Vageesh Jain (UCL Institute for Global Health) and Professor Paula Lorgelly (UCL Epidemiology & Health).
The UK has met its target of offering a first Covid-19 vaccine dose to its top four priority groups by mid-February. All people over 70, frontline health and care staff, care home residents and extremely clinically vulnerable people have been offered a vaccine, with more than 15 million people having now taken a first dose.
The Joint Committee on Vaccination and Immunisation’s (JCVI) strategy has prioritised giving vaccines to those most likely to die from Covid-19 – predominantly elderly people. It reflects the stance taken by many countries and by the World Health Organization (WHO), and has been widely supported so far.
Why you shouldn t get a covid antibody test after your vaccine sfgate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfgate.com Daily Mail and Mail on Sunday newspapers.
Analysis Demonstrates Effectiveness of LY-CoV555 Antibody in Preventing Symptomatic COVID-19
Analysis Demonstrates Effectiveness of LY-CoV555 Antibody in Preventing Symptomatic COVID-19
DURHAM, N.C., Jan. 25, 2021 Researchers from the COVID-19 Prevention Network (CoVPN) announced that the monoclonal antibody (mAb), LY-CoV555 (bamlanivimab), evaluated in a Phase III trial significantly reduces the risk of contracting symptomatic COVID-19 as well as reduces the clinical course of COVID-19 in study participants who did become symptomatic. The study, CoVPN 3501, was conducted in collaboration with Eli Lilly and Company in skilled nursing facilities (SNFs) across the United States. Residents and staff at SNFs participated in the trial.
A total of 1,097 participants (340 residents, 757 staff) were randomized to receive either a single 4,200 mg dose of LY-CoV555 or placebo (saline). Half of the study participants received LY-CoV555 and h
The U.S. new cases 7-day rolling average are 21.7 % LOWER than the 7-day rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 4.4 %
LOWER than the rolling average one week ago. U.S. deaths due to coronavirus are now 11.0 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 188,952
U.S. Coronavirus hospitalizations are at an elevated 119,927
U.S. Coronavirus deaths are at an elevated 3,955
U.S. Coronavirus immunizations have been administered to 5.3 % of the population
The 7-day rolling average rate of growth of the pandemic shows new cases improved, hospitalizations improved, and deaths worsened